Heterogeneous appearance of the liver, periportal involvement, diffuse low signal intensity of spleen on T2-weighted MRI, and thickened bowel wall may be helpful imaging findings when accompanied by presence or history of chronic inflammatory disease and clinical suspicion for amyloidosis
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Involvement of the abdominal organs has variable presentations mostly without specific findings.
📊
Key Findings & Data:The objective of this pictorial essay was to illustrate the computed tomography and magnetic resonance imaging (MRI) findings of abdominal involvement in systemic amyloidosis.
💡
Conclusion & Impact:Heterogeneous appearance of the liver, periportal involvement, diffuse low signal intensity of spleen on T2-weighted MRI, and thickened bowel wall may be helpful imaging findings when accompanied by presence or history of chronic inflammatory disease and clinical suspicion for amyloidosis
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Involvement of the abdominal organs has variable presentations mostly without specific findings. The objective of this pictorial essay was to illustrate the computed tomography and magnetic resonance imaging (MRI) findings of abdominal involvement in systemic amyloidosis. Heterogeneous appearance of the liver, periportal involvement, diffuse low signal intensity of spleen on T2-weighted MRI, and thickened bowel wall may be helpful imaging findings when accompanied by presence or history of chronic inflammatory disease and clinical suspicion for amyloidosis
🔖
Cite This Article
ÖZCAN, H. N., HALİLOĞLU, M., SÖKMENSÜER, C., AKATA, D., ÖZMEN, M. N., KARCAALTINCABA, M. (2017). Imaging for abdominal involvement in amyloidosis. Diagnostic and Interventional Radiology, Cilt: 23 - Sayı: 4, 282–285. https://ajindex.com/articles/196090
Glenner GG. Amyloid deposits and amyloido- sis. The beta-fibrilloses (first of two parts). N Engl J Med 1980; 302:1283–1292. [CrossRef] Monzawa S, Tsukamoto T, Omata K, Hosoda K, Araki T, Sugimura K. A case with primary amyloidosis of the liver and spleen: radio- logic findings. Eur J Radiol 2002; 41:237–241. [CrossRef] Scott PP, Scott WW, Jr, Siegelman SS. Amyloi- dosis: an overview. Semin Roentgenol 1986; 21:103–112. [CrossRef] Kyle RA, Bayrd ED. Amyloidosis: review of 236 cases. Medicine 1975; 54:271–299. [CrossRef] Kim SH, Han JK, Lee KH, et al. Abdominal amy- loidosis: spectrum of radiological findings. Clin Radiol 2003; 58:610–620. [CrossRef] Urban BA, Fishman EK, Goldman SM, et al. CT evaluation of amyloidosis: spectrum of disease. Radiographics 1993; 13:1295–1308. [CrossRef] Tada S, Iida M, Yao T, et al. Gastrointestinal amy- loidosis: radiologic features by chemical types. Radiology 1994; 190:37–42. [CrossRef] Pear BL. Other organs and other amyloids. Se- min Roentgenol 1986; 21:150–164. [CrossRef] Gertz MA, Kyle RA. Hepatic amyloidosis: clini- cal appraisal in 77 patients. Hepatology 1997; 25:118–121. [CrossRef] Benson L, Hemmingsson A, Ericsson A, et al. Magnetic resonance imaging in primary amyloi- dosis. Acta Radiol 1987; 28:13–15. [CrossRef] Rafal RB, Jennis R, Kosovsky PA, Markisz JA. MRI of primary amyloidosis. Gastrointest Radiol 1990; 15:199–201. [CrossRef] Ekelund L. Radiologic findings in renal amy- loidosis. AJR Am J Roentgenol 1977; 129:851– 853. [CrossRef] Moon WK, Kim SH, Im JG, et al. Castleman dis- ease with renal amyloidosis: imaging findings and clinical significance. Abdom Imaging 1995; 20:376–378. [CrossRef] Kawashima A, Alleman WG, Takahashi N, Kim B, King BF Jr, LeRoy AJ. Imaging evaluation of amy- loidosis of the urinary tract and retroperitoneum. Radiographics 2011; 31:1569–1582. [CrossRef] Tada S, Iida M, Yao T, et al. Gastrointestinal amy- loidosis: radiologic features by chemical types. Radiology 1994; 190:37–42. [CrossRef] Seliger G, Krassner RL, Beranbaum ER, Miller F. The spectrum of roentgen appearance in am- yloidosis of the small and large bowel:radio- logic–pathologic correlation. Radiology 1971; 100:63–70. [CrossRef] Menke DM, Kyle RA, Fleming CR, et al. Symp- tomatic gastric amyloidosis in patients with primary systemic amyloidosis. Mayo Clin Proc 1993; 68:763–767. [CrossRef]